Defining the role of the RGS12 locus in macrophage function
Active Project Grant Awarded Last action
- Award ID
- F31AI191426
- Recipient
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $171,269
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 40% complete
- Place of performance
- Durham, NC 27710, USA
Award details come from USAspending.gov.
About this award
The National Institute of Allergy and Infectious Diseases awarded Duke University $171,269 on November 1, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the role of the RGS12 locus in macrophage function.
The research uses the zebrafish-Mycobacterium marinum model and human tuberculosis patient cohort datasets to examine how RGS12B regulates macrophage epithelioid transformation and granuloma bacterial containment. Preliminary data indicate that RGS12 enrichment in epithelioid macrophages correlates with increased TB severity, and loss of RGS12B disrupts both epithelioid transformation and granuloma integrity. The project will investigate mechanisms by which RGS12B controls macrophage behavior and G-protein signaling in the context of mycobacterial granulomas, with the goal of advancing understanding of how macrophage regulation influences tuberculosis pathogenesis.
Work is performed in Durham, North Carolina, with a period of performance from November 1, 2025, through April 30, 2028. The award is a project grant, a form of assistance funding supporting individual researchers and institutions to conduct biomedical research in infectious diseases and related immunologic and allergic conditions.
Description
- Abstract
- Macrophages are vital components of a diverse and extensive set of physiological processes, and rely on precise response to both internal and external cues to perform their functions. G-protein signaling comprises a significant proportion of these functional cues, and thus is a significant and consequential mechanism of macrophage regulation. Regulators of G-protein signaling (RGS) proteins are a family of related proteins that exert control over G-protein pathways by accelerating the termination of signaling cascades. RGS12 is the largest member of the RGS family and possesses a number of protein-protein interaction domains in addition to this G-protein regulation capability. The goal of this proposal is to investigate how RGS12 influences macrophage function in the context of a leukocyte-rich structure known as a granuloma. In response to persistent inflammatory stimuli including mycobacterial infection, macrophages aggregate into a granuloma structure, and a subset of these cells undergo a transformation into epithelioid macrophages, which are critical to the integrity of the granuloma structure. Using the zebrafish-mycobacterium marinum model and available human tuberculosis (TB) patient cohort datasets, we have found that the zebrafish ortholog RGS12B is enriched in the epithelioid macrophage population and that RGS12 is associated with increased TB severity, while preliminary data suggests that loss of RGS12B disrupts macrophage epithelioid transformation and granuloma bacterial containment. Thus, we hypothesize that RGS12B is an important regulator of macrophage function and identity, and will utilize the zebrafish-M. Marinum model to investigate the mechanism of this interaction in the context of a mycobacterial granuloma. Completion of the proposed work will represent a significant contribution to our understanding of how macrophage behavior and G-protein signal regulation can alter function. The findings will be relevant to the development of host-direct therapies targeting the granuloma structure, and could also extend to a number of blood and lung-related disorders in which RGS protein irregularities have been implicated.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $43,742 | |
| Amendment | $564 | |
| Amendment | $42,321 | |
| Amendment | $0 | |
| Amendment | $42,321 | |
| Amendment | $0 | |
| Original award | $42,321 |
Quick answers
Who received award F31AI191426?
F31AI191426 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 1, 2025.
How much is award F31AI191426 worth?
$171,269 has been obligated on F31AI191426.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award